Literature DB >> 30888660

Visual Defects and Ageing.

Sergio Claudio Saccà1, Carlo Alberto Cutolo2, Tommaso Rossi3.   

Abstract

Many diseases are related to age, among these neurodegeneration is particularly important. Alzheimer's disease Parkinson's and Glaucoma have many common pathogenic events including oxidative damage, Mitochondrial dysfunction, endothelial alterations and changes in the visual field. These are well known in the case of glaucoma, less in the case of neurodegeneration of the brain. Many other molecular aspects are common, such as the role of endoplasmic reticulum autophagy and neuronal apoptosis while others have been neglected due to lack of space such as inflammatory cytokine or miRNA. Moreover, the loss of specific neuronal populations, the induction of similar mechanisms of cell injury and the deposition of protein aggregates in specific anatomical areas are very similar events between these diseases. Intracellular and/or extracellular accumulation of protein aggregates is a key feature of many neurodegenerative disorders. The existence of abnormal protein aggregates has been documented in the RGCs of glaucomatous patients such as the anomalous Tau protein or the β-amyloid accumulations. Intra-cell catabolic processes also appear to be common in both glaucoma and neurodegeneration. They also help us to understand how the basis between these diseases is common and how the visual aspects can be a serious problem for those who are affected.

Entities:  

Keywords:  Alzheimer’s disease; Autophagy; Endothelial dysfunction; Glaucoma; Mitochondria; Oxidative stress; Parkinson’s disease; Trabecular meshwork; Visual field

Mesh:

Substances:

Year:  2019        PMID: 30888660     DOI: 10.1007/978-981-13-3681-2_14

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  1 in total

1.  Volume of Lateral Geniculate Nucleus in Patients with Glaucoma in 7Tesla MRI.

Authors:  Ewa Kosior-Jarecka; Anna Pankowska; Piotr Polit; Andrzej Stępniewski; Mark Roger Symms; Paulina Kozioł; Tomasz Żarnowski; Radosław Pietura
Journal:  J Clin Med       Date:  2020-07-26       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.